Lonza Group traded at 529.60 this Tuesday July 5th, increasing 4.80 or 0.91 percent since the previous trading session. Looking back, over the last four weeks, Lonza Group gained 6.99 percent. Over the last 12 months, its price fell by 20.46 percent. Looking ahead, we forecast Lonza Group to be priced at 505.80 by the end of this quarter and at 467.66 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Covestro 30.79 -1.67 -5.14% -42.66%
Akzo Nobel 61.38 -1.34 -2.14% -40.49%
Alcon AG 67.84 -0.12 -0.18% 3.92%
Almirall SA 10.87 0.08 0.74% -28.01%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
BASF 39.33 -2.56 -6.11% -40.45%
Bayer 55.52 -1.72 -3.00% 9.55%
Beiersdorf 98.76 -0.44 -0.44% -4.58%
DSM 140.10 1.15 0.83% -11.86%
Fresenius Medical Care 47.26 -0.40 -0.84% -30.19%
Fresenius 28.53 -0.79 -2.69% -34.89%
Geberit 465.40 -3.40 -0.73% -32.96%
Genmab 2,407.00 54.00 2.29% -8.41%
Givaudan 3,462.00 19.00 0.55% -19.75%
GN Store Nord 245.10 -5.60 -2.23% -57.00%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Hikma Pharmaceutical 1,638.00 -16.00 -0.97% -35.94%
Johnson Matthey 1,818.50 -83.50 -4.39% -40.10%
Merck 167.85 2.45 1.48% 1.39%
Novartis 80.91 -0.74 -0.91% -4.31%
Philips 20.07 -0.08 -0.37% -50.12%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Sanofi 97.12 -1.22 -1.24% 11.93%
Sika AG 212.60 -11.00 -4.92% -30.23%
Smith & Nephew PLC 1,130.00 -10.00 -0.88% -28.91%
Solvay 74.82 -4.04 -5.12% -29.71%
UCB 82.60 -0.04 -0.05% -6.92%
William Demant Holding 269.40 1.20 0.45% -26.47%

Indexes Price Day Year
CH20 10884 181.71 1.70% -9.94%

Lonza Group
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.